Protocols: Editas recruits a Bristol-Myers vet as CSO; Eli Lilly gets a dubious honor for Alzheimer's drug; Voyager in the spotlight
Cambridge, MA-based gene editing stalwart Editas has recruited a Bristol-Myers vet for the CSO’s job. Charles Albright moves in after a stint as VP …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
